About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials | 3,202 Studies Recruiting

Clinical TrialsDepression

Depression Clinical Trials

Browse 3,202 clinical trials for depression. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 761-780 of 3,202 trials

WithdrawnSSIPP vs. PST vs. WLCThe COVID-19 pandemic and continued lockdown measures have led to social isolation that is likely disproportionately affecting community-dwelling seniors.NCT04887350·London, Ontario TerminatedPlacebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in FemalesThe investigators propose to determine if 8 weeks of dietary augmentation with oral 5g creatine monohydrate daily and 100 mg of 5-hydroxytryptophan (5-HTP) twice daily reduces…NCT02922725·Salt Lake City, Utah

Related Searches

major depressivetrials mddtrials

Data from ClinicalTrials.govTerms

UnknownImproving Health Care in Major Depressive DisorderThis project aims to improve the health care provided to people with major depressive disorder (MDD), a disease which is a top cause of disability worldwide.NCT05816018·Milan

RecruitingTDM-Guided Treatment With SSRIs in Hospitalized Adults and ChildrenDepression in childhood and adolescence is a serious and increasing public-health problem associated with profound short- and long-term consequences, including impaired social and…NCT07478796·Poznan, Greater Poland Voivodeship

CompletedSafety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyThe purpose of this study is to determine the long-term safety and tolerability of vortioxetine, once daily (QD), in participants with major depressive disorder.NCT01152996

CompletedAZD6765 Severe Major Depressive Disorder (MDD) IVThe purpose of this research study is to determine whether AZD6765 has an effect on the patient's depression when taken together with current depression medication.NCT00781742·Little Rock, Arkansas and 26 others

CompletedFunctional Outcome in Postpartum Depression in Women Treated With DesvenlafaxinePostpartum depressed women suffer from functional impairment in their mood, thoughts, cognition and physical well being leading to poor motivation, bonding difficulties, decreased…NCT01527786·Vancouver, British Columbia

UnknownComparison of Yuxintine With Placebo in Treatment of MDDThe purpose of this study is to determine whether Yuxintine Capsule in different doses are effective in the treatment of Depression.NCT02395263·Beijing, Beijing Municipality and 9 others

CompletedCitalopram Titration in Early Non-responder Patients With Major Depressive DisordersMajor depressive disorder is a common mental disorder and the leading cause of disability worldwide.NCT03899285·Montreal East, Quebec

TerminatedFamily Based Treatment of Depressed AdolescentsThe purpose of this project is to assess the effectiveness of a family-based therapy (Attachment based family therapy-ABFT) for Norwegian adolescents (13-17 years) referred to…NCT00700609·Stavanger, Rogaland

CompletedEvaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed PatientsThe purpose of this study is to evaluate three different continuation treatments after acute ECT concerning efficacy and impact on cognition in severly depressed patients.NCT00437385·Berlin, State of Berlin

CompletedCognitive Reappraisal in Adolescents With Major DepressionMajor depression (MD) is common during adolescence and associated with significant morbidity and mortality.NCT03957850·Munich, Bavaria

CompletedSafety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major DepressionThis study examines the difference in the effectiveness of two natural compounds, eicosapentanoic (EPA) and docosahexanoic (DHA)omega-3 fatty acids, in treating major depressive…NCT00361374·Boston, Massachusetts

CompletedMemantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major DepressionThe purpose of this study is to determine whether taking the medication memantine reduces impairment of memory and attention associated with electroconvulsive therapy.NCT00186498·Stanford, California

CompletedVenlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)This is a phase 3, flexible-dose, open-label, multi-center study.NCT01485887·Inzai, Chiba and 24 others

UnknownRESET-psychotherapy: the Effectiveness of Trauma-focused Therapy in Patients With Depression and Childhood TraumaDepression is a debilitating psychiatric disorder with a recurrent and progressive course.NCT05149352·Amsterdam, North Holland and 2 others

UnknownLinear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One DayThis is a pilot interventional study to investigate the acceptability, tolerability, and side effect profile for varying numbers of treatment sessions/day of a new rTMS treatment…NCT03986658·Ottawa, Ontario

CompletedAn Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel SyndromeWe hypothesize that duloxetine treatment will be associated with improvement in symptoms of IBS, particularly abdominal pain, in individuals without comorbid major depressive…NCT00401258·Belmont, Massachusetts

TerminatedRisks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesStudies have shown that people with certain disorders have an increased risk of developing a condition called Metabolic Syndrome (MS).NCT01310140·Boston, Massachusetts

CompletedImproving Representative Payeeship for People With Psychiatric Disabilities and Their FamiliesRepresentative payees, mostly family members, manage Social Security Administration funds of more than one million people with psychiatric disabilities.NCT00924976·Chapel Hill, North Carolina

PreviousPage 39 of 161Next